- Capital Cube•2 months ago
Medistim ASA relative valuation is OVERVALUED and it has a fundamental analysis score of 97.Our analysis is based on comparing Medistim ASA with the following peers – Surgical Innovations Group plc, PAUL HARTMANN AG, Eckert & Ziegler Strahlen- und Medizintechnik AG and aap Implantate AG (SUN-GB, PHH2-DE, EUZ-DE and AAQ-DE).Medistim ASA has shown good performance […] (Read more...) The post Medistim ASA: Leads amongst peers with strong fundamentals appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
|Bid||61.50 x 3000|
|Ask||64.50 x 34000|
|52wk Range||40.00 - 66.00|
|Day's Range||64.50 - 64.50|
|Avg Vol (3m)||7,249|
As of 3:08 AM EDT. Market closed.